Last 12 months
Inside the activity.
0 purchase rows · 28 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 5 |
| Mar 2026 | 0 | 5 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 2 |
| Jun 2026 | 0 | 3 |
| Jul 2026 | 0 | 2 |
| Aug 2026 | 0 | 11 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 02, 2026 Filed Jan 6, 2026 21:11 UTC |
Barrocas MarkDirector · Chief Executive Officer
|
GrantRestricted Share Units · Derivative | 158,800 | $0.00 | $0.00 |
DisclosureSEC source: 0001987144-26-000003 · wk-form4_1767733874.xml · derivative · entry 1 Barrocas Mark · CIK 0001987144 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 158,800 Underlying: Ordinary Shares · 158,800 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Share Unit represents the contingent right to receive one ordinary share. F2 · derivative.exercise_date: These Restricted Share Units were granted on January 2, 2026 and vest in three equal annual installments beginning on February 28, 2027. Excludes additional Performance Restricted Share Units granted on January 2, 2026 and vesting only upon the achievement of certain performance criteria. F2 · derivative.expiration_date: These Restricted Share Units were granted on January 2, 2026 and vest in three equal annual installments beginning on February 28, 2027. Excludes additional Performance Restricted Share Units granted on January 2, 2026 and vesting only upon the achievement of certain performance criteria. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.